Chongqing Development: Chairman Wang Anjin and general manager Ai Yun resigned
Financial Associated Press, Dec. 30, Chongqing Development announced that Wang Anjin applied for resignation from the chairman of the ninth board of directors, the strategy committee of the board of directors and the nomination committee due to job transfer; Ai Yun proposed to resign as general manager of the company due to job adjustment.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Briefing May 19, 2022 11:54 AM
· Consumer Staples
Huzhou: there is no time limit for non registered residence residents to continuously pay social security when purchasing houses in central cities
Jan 30, 2026 06:00 PM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Briefing May 18, 2022 04:45 PM
Taier shares: the contract dispute case against Cao Linbin was accepted by the court
Healthcare
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
Briefing Apr 02, 2022 02:03 PM
· Technology
Central Co., Ltd. comprehensively raised the price of p-type monocrystalline silicon wafer
In-depth
Healthcare
Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:30 PM
In-depth
Healthcare
Yunnan Baiyao: An Oriental Mystery in the Limelight (1/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:00 PM
Briefing Jan 26, 2022 02:39 PM
· Technology
The Commerce Department said the shortage of chips would continue for at least six months
See more
Read next
Insight
In-depth
Automotive · Analysis
Investment Is Booming, Orders Are Rising, but Robots Are Still Learning How to Deliver
Mar 23, 2026 10:29 AM
Insight
In-depth
Automotive · Analysis
Thinking of ASEAN as a single market is the biggest miscalculation for Chinese companies
Feb 19, 2026 12:00 PM
Insight
In-depth
Consumer Staples, Industrials, Communication
You're Invited: China's Innovation, Up Close
Feb 10, 2026 04:21 PM
Insight
In-depth
Automotive · Analysis
CES 2026 in Numbers | From Shenzhen to Las Vegas: Huaqiangbei’s Year-End Report
Jan 15, 2026 09:42 PM